Decision uncertainty associated with reliance on surrogate endpoints is a risk to patients and society. HTA agencies may develop more detailed methodological guidance for consistent selection and evaluation of health technologies without definitive final patient-relevant outcome evidence at the time of the assessment.

Surrogate endpoints in health technology assessment: an international review of methodological guidelines

Oriana Ciani;Carlo Federici;
2020

Abstract

Decision uncertainty associated with reliance on surrogate endpoints is a risk to patients and society. HTA agencies may develop more detailed methodological guidance for consistent selection and evaluation of health technologies without definitive final patient-relevant outcome evidence at the time of the assessment.
2020
2020
Grigore, Bogdan; Ciani, Oriana; Dams, Florian; Federici, CARLO BALDASSARRE; de Groot, Saskia; Möllenkamp, Meilin; Rabbe, Stefan; Shatrov, Kosta; Zemplenyi, Antal; Taylor, Rod S.
File in questo prodotto:
File Dimensione Formato  
Grigore2020_Article_SurrogateEndpointsInHealthTech.pdf

accesso aperto

Descrizione: articolo
Tipologia: Pdf editoriale (Publisher's layout)
Licenza: Creative commons
Dimensione 892.49 kB
Formato Adobe PDF
892.49 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11565/4027585
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 32
social impact